Report Description

India ornidazole market is expected to grow at a steady rate during the forecast period. The India ornidazole market is driven by the widespread use of the antibiotic in treatment of protozoans infections. Additionally, the extensive use of the drug in the treatment of trichomoniasis is further expected to fuel the market growth through FY2026. Furthermore, the use of drug in treatment of Crohn’s disease after bowel resection is further expected to create lucrative opportunities for the market growth over the next five years.

The India ornidazole market is segmented based on composition, source, form, route of administration, distribution channel, application, end user, company and region. Based on source, the market can be split in in-house and contract manufacturing organizations. The contract manufacturing organizations segment is expected to witness significant growth during the forecast period on account of the increasing outsourcing being done by the major pharmaceutical companies for the manufacturing of APIs and drugs so that they can focus on their R&D activities and expansion plans. Additionally, these organizations have the capability to produce and provide bulk quantities of formulation to their clients at affordable prices and in lesser time.

The major players operating in the India ornidazole market are Intas Pharmaceuticals Ltd., Wellona Pharma Pvt. Ltd., Salvavidas Pharmaceutical Pvt. Ltd., Actiza Pharmaceutical Pvt. Ltd., Facemed Pharmaceuticals Pvt. Ltd., Taj Pharmaceuticals Ltd., Abbott Healthcare Pvt. Ltd., Anuja Healthcare Ltd., Heer Pharma Pvt. Ltd., Intra Labs India Pvt. Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India ornidazole market from FY2016 to FY2019.
  • To estimate and forecast the market size of India ornidazole market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India ornidazole market based on composition, source, form, route of administration, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India ornidazole market.
  • To identify drivers and challenges for India ornidazole market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India ornidazole market.
  • To identify and analyze the profile of leading players operating in India ornidazole market.
  • To identify key sustainable strategies adopted by market players in India ornidazole market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India ornidazole market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Ornidazole manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to ornidazole

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India ornidazole market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Ornidazole Market, By Composition:
    • Single
    • Combinational
  • India Ornidazole Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Ornidazole Market, By Form:
    • Tablet
    • Capsule
    • Injection
    • Others
  • India Ornidazole Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Ornidazole Market, By Distribution Channel:
    • Online
    • Offline
  • India Ornidazole Market, By Application:
    • Vaginal Infections
    • Urinary Tract Infections
    • Intestinal Infections
    • Trichomoniasis
    • Others
  • India Ornidazole Market, By End User:
    • Adult
    • Pediatric
  • India Ornidazole Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India ornidazole market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Ornidazole market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Ornidazole Market

4.    Executive Summary

5.    Manufacturing Ornidazole

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Ornidazole

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Ornidazole Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Composition (Single v/s Combinational)

7.2.2.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.3.     By Form (Tablet, Injection, Capsule, Others)

7.2.4.     By Route of Administration (Oral v/s Intravenous)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Application (Vaginal Infections, Urinary Tract Infections, Intestinal Infections, Trichomoniasis, Others)

7.2.7.     By End User (Adult v/s Pediatric)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Intas Pharmaceuticals Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Wellona Pharma Pvt. Ltd.

14.1.3.  Salvavidas Pharmaceutical Pvt. Ltd.

14.1.4.  Actiza Pharmaceutical Pvt. Ltd.

14.1.5.  Facemed Pharmaceuticals Pvt. Ltd.

14.1.6.  Taj Pharmaceuticals Ltd.

14.1.7.  Abbott Healthcare Pvt. Ltd.

14.1.8.  Anuja Healthcare Ltd.

14.1.9.  Heer Pharma Pvt. Ltd.

14.1.10.                Intra Labs India Pvt. Ltd.

15.  Strategic Recommendations

About Us & Disclaimer 

Figures and Tables

Frequently asked questions






Sakshi Bajaal

Business Consultant
Press Release

India Gabapentin Market to grow at a steady rate During the Forecast Period

Oct, 2020

Growing epilepsy and restless legs syndrome is expected to drive the growth of India Gabapentin market during the forecast period.